20 June 2013
Keywords: lilly, almita, enters, ph, iii, trial, sclc
Article | 30 October 2006
US drugmaker Eli Lilly says that it has initiated a Phase III trial of its anticancer agent Alimta (pemetrexed for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 October 2006
19 June 2013
© 2013 thepharmaletter.com